Malignant Pleural Mesothelioma Outcomes in the Era of Combined Platinum and Folate Antimetabolite Chemotherapy

Introduction. Malignant pleural mesothelioma (MPM) is associated with a poor prognosis. Palliative platinum-based chemotherapy may help to improve symptoms and prolong life. Since 2004, the platinum is commonly partnered with a folate antimetabolite. We performed a review investigating if survival h...

Descripción completa

Detalles Bibliográficos
Autores principales: Saint-Pierre, Mathieu D., Pease, Christopher, Mithoowani, Hamid, Zhang, Tinghua, Nicholas, Garth A., Laurie, Scott A., Wheatley-Price, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437405/
https://www.ncbi.nlm.nih.gov/pubmed/26316950
http://dx.doi.org/10.1155/2015/590148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437405/
https://www.ncbi.nlm.nih.gov/pubmed/26316950
http://dx.doi.org/10.1155/2015/590148

Ejemplares similares